Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MolecularHUB Gives Scientific Information on Fast-moving Diseases

Published: Thursday, October 25, 2012
Last Updated: Thursday, October 25, 2012
Bookmark and Share
A scientific gateway website that will provide molecular and genetic information on infectious and emerging diseases has been released by Purdue University.

The MolecularHUB site was announced Wednesday (Oct. 24) at the annual meeting of the Association for Molecular Pathology (AMP), which is being held in Long Beach, Calif.

James McGlothlin, a Purdue associate professor of health sciences and director of the site, said MolecularHUB will actively foster an environment of co-creation and collaboration. The goal of the site is to expand the current knowledge base of genetic markers, gene sequencing and molecular testing related to infectious diseases, chronic diseases and emerging diseases to help speed the identification and treatment of these diseases.

"With this site we have the opportunity to improve public health care and patient outcomes by providing free, easy access to the latest information," McGlothlin said. "The half-life of information in this field is very short; it's one of the fastest moving disciplines in modern science. So this site will keep professionals up-to-date with the latest scientific information."

The site, http://www.molecularHUB.org, is exclusively sponsored by BD (Becton Dickinson and Company), a Fortune 500 medical supply company.

"The goal is involve anyone working with molecular diagnostics so we can combine and leverage resources and capabilities," McGlothlin said. "This will allow us to standardize work practices and provide training and programs that will enhance scientific knowledge in this field."

Gregory Meehan, vice president for diagnostic systems and molecular diagnostics at BD Diagnostics, one of three divisions of BD, said the site has the potential to bring together medical and scientific communities.

"The valuable information and experiences of the global laboratory, scientific and academic community will come together through MolecularHUB in developing and sharing best practices across the spectrum of molecular-based diagnostic applications, laboratory efficiency, and clinical and economic outcomes," Meehan said.

The site is built on the Purdue-developed platform HUBzero, which has been used by more than 40 scientific, engineering and medical gateway sites as resources for scientific communities.

"MolecularHUB will be accessible to the more than 600,000 visitors of other hubs each year," McGlothlin said. "This will foster other opportunities for synergistic collaborations among disciplines such as engineering, laboratory design and ergonomics, and drug delivery."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Technique Yields Drug, Biomedical Test Results in One Minute
Slug flow microextraction makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine.
Tuesday, October 14, 2014
Helping Genes Get Out of the Starting Blocks Faster
Yeast can quickly adapt to changes in its environment with the help of molecules known as long non-coding RNAs, a Purdue study shows.
Friday, February 21, 2014
Purdue Innovation could Improve Personalized Cancer-Care Outcomes
An innovation could improve therapy selection for personalized cancer care by helping specialists better identify the most effective drug treatment combinations for patients.
Friday, August 16, 2013
Purdue Researcher Invents Molecule that Stops SARS
A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease.
Tuesday, November 18, 2008
Researcher Hits Bulls-Eye for Antibiotic Target
Purdue researcher determines the structure of a protein that controls the starvation response of E. coli.
Wednesday, August 23, 2006
Purdue Scientists Treat Cancer with RNA Nanotechnology
Microscopic particles possess both the right size to gain entry into cells and also the right structure to carry other therapeutic strands of RNA inside with them.
Tuesday, September 20, 2005
Scientific News
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
New Genetic Risk Factors for Myopia Discovered
Genes and environment determine short-sightedness.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
New Neurodevelopmental Syndrome Identified
Study pinpoints underlying genetic mutations, raising hopes for targeted therapies.
Uncovering How Some Breast Cancers Resist Treatment
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!